Companies / Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc.
OTC: SGMOCIK 1001233RICHMOND, CA
Financials · FY2025
Ownership
414.3M shares outstanding · as of May 11, 2026
Ownership
| Insiders | 0.94% | 3,880,134 |
| 10%+ / strategic | 9.75% | 40,400,067 |
| Institutions | 16.27% | 67,413,309 |
| Public float | 73.04% | 302,595,337 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 6
View all →| Insider | % of shares | Shares |
|---|---|---|
Macrae SandyCEOPRESIDENT, CEO AND DIRECTOR · Director | 0.46% | 1,895,043 |
Duraibabu PrathyushaPRINCIPAL FINANCIAL OFFICER | 0.16% | 660,042 |
Willoughby Scott B.SVP, CHIEF LEGAL OFFICER, SECY | 0.16% | 647,370 |
Dubois-Stringfellow NathalieSVP-CHIEF DEVELOPMENT OFFICER | 0.08% | 328,733 |
Jain NikunjPrincipal Accounting Officer | 0.06% | 235,292 |
Davis Gregory DHead of Research & Technology | 0.03% | 113,654 |
Institutional holders 110
View all →| Holder | Value | % of shares |
|---|---|---|
| $5.04M | 2.90% | |
| $1.92M | 1.10% | |
| $1.82M | 1.05% | |
| $1.55M | 1.51% | |
| $1.31M | 1.28% | |
| $1.23M | 0.70% | |
| $1.13M | 1.10% | |
| $947.3K | 0.93% | |
| $897.6K | 0.52% | |
| $719.6K | 0.41% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | Dubois-Stringfellow Nathalie Executive | Sell | Common Stock | $89.2K | -346K -50.97% | 332,769 0.08% of shares | low |
| Jan 22, 2026 | Macrae Sandy CEO | Other | Common Stock | $41.0K | -103K -5.02% | 1,946,584 0.47% of shares | low |
| Apr 22, 2026 | Davis Gregory D Executive | Sell | Common Stock | $17.7K | -70K -37.72% | 115,284 0.03% of shares | low |
| Feb 25, 2026 | Macrae Sandy CEO | Other | Common Stock | $15.8K | -34K -1.73% | 1,907,656 0.46% of shares | low |
| Jan 22, 2026 | Duraibabu Prathyusha Executive | Other | Common Stock | $14.6K | -37K -5.26% | 660,042 0.16% of shares | low |
| Jan 22, 2026 | Dubois-Stringfellow Nathalie Executive | Other | Common Stock | $14.6K | -37K -5.03% | 693,128 0.17% of shares | low |
| Jan 22, 2026 | Willoughby Scott B. Executive | Other | Common Stock | $14.6K | -37K -5.22% | 665,410 0.16% of shares | low |
| Feb 25, 2026 | Dubois-Stringfellow Nathalie Executive | Other | Common Stock | $5.8K | -12K -1.79% | 678,711 0.16% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Armistice Capital, LLC | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| SGMO | — | 800677106 |